Sponsor:
M.D. Anderson Cancer Center
Code:
NCT02918474
Conditions
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage IA Breast Cancer AJCC v8
Anatomic Stage IB Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Decision Aid
Questionnaire Administration
Brief summary:
Conditions
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage IA Breast Cancer AJCC v8
Anatomic Stage IB Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage IIA Breast Cancer AJCC v8
Study ID
NCT02918474
Start date
Apr 28, 2017
Status verified date
Apr, 2026
Completion date
Sep 30, 2026
Anticipated
Primary completion date
Sep 30, 2026
Anticipated
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
15 participants
Anticipated
Intervention Model
Single group
Primary purpose
Supportive Care
Arms
experimental: Supportive care (decision making tool)
Interventions
Decision Aid
Questionnaire Administration
Primary outcome measure
Central contacts
Locations
M D Anderson Cancer Center
Recruiting
Houston, Texas, United States, 77030
Contacts
Abenaa M. Brewster
713-745-4949Principal Investigator:
Abenaa M. Brewster
Sponsor
M.D. Anderson Cancer Center
Last update posted
Apr 16, 2026
Last verified
Apr, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by M.D. Anderson Cancer Center on 2026-04-16.